These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 6812011

  • 1. Current status of the etiology and management of dysmenorrhea in adolescence.
    Alvin PE, Litt IF.
    Pediatrics; 1982 Oct; 70(4):516-25. PubMed ID: 6812011
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Antagonist of prostaglandin synthesis in the treatment of dysmenorrhea].
    Nesheim B.
    Tidsskr Nor Laegeforen; 1979 Jun 10; 99(16):847-8. PubMed ID: 462454
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drugs for dysmenorrhea.
    Med Lett Drugs Ther; 1979 Oct 05; 21(20):81-4. PubMed ID: 481317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A clinical evaluation of the antiarthritic agents.
    Bhalla AK, Simon LS.
    Compr Ther; 1984 Aug 05; 10(8):40-50. PubMed ID: 6467883
    [No Abstract] [Full Text] [Related]

  • 10. Editorial: a new line on dysmenorphea.
    Br Med J; 1975 May 31; 2(5969):461-2. PubMed ID: 1148658
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors].
    Lundström V.
    Lakartidningen; 1979 Feb 21; 76(8):614-6. PubMed ID: 105214
    [No Abstract] [Full Text] [Related]

  • 12. Primary dysmenorrhea: alleviation by an inhibitor of prostaglandin synthesis and action.
    Schwartz A, Zor U, Lindner HR, Naor S.
    Obstet Gynecol; 1974 Nov 21; 44(5):709-12. PubMed ID: 4213653
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Experience with the treatment of primary dysmenorrhea].
    Horváth B, Turay A, Horváth S.
    Orv Hetil; 1981 Apr 05; 122(14):823-5. PubMed ID: 7254808
    [No Abstract] [Full Text] [Related]

  • 18. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR, Eskes TK.
    Ned Tijdschr Geneeskd; 1984 Jan 14; 128(2):73-8. PubMed ID: 6422313
    [Abstract] [Full Text] [Related]

  • 19. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V, Gréen K, Svanborg K.
    Acta Obstet Gynecol Scand Suppl; 1979 Jan 14; 87():51-6. PubMed ID: 111466
    [Abstract] [Full Text] [Related]

  • 20. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P, Forsling ML, Akerlund M.
    Obstet Gynecol; 1981 Aug 14; 58(2):206-8. PubMed ID: 7254732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.